kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - Ομοιοστασία ασβεστίου - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
tarmed 4% (w/w) σαπων για το τριχωτο τησ κεφαλησ (σαμπουαν)
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α - coal tar solution - ΣΑΠΩΝ ΓΙΑ ΤΟ ΤΡΙΧΩΤΟ ΤΗΣ ΚΕΦΑΛΗΣ (ΣΑΜΠΟΥΑΝ) - 4% (w/w) - 0008050439 coal tar solution 40.000000 mg - tars
lyosan plus
farmedia ae - losartan potassium, hydrochlorothiazide - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - (50+12,5)mg/tab - ineof00931 - losartan potassium - 50.000000 mg; 0000058935 - hydrochlorothiazide - 12.500000 mg - losartan and diuretics
lyosan plus
farmedia ae - losartan potassium, hydrochlorothiazide - ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ - (100+25)mg/tab - ineof00931 - losartan potassium - 100.000000 mg; 0000058935 - hydrochlorothiazide - 25.000000 mg - losartan and diuretics
duspatalin retard 200mg prolonged release capsule, hard
viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - mebeverine hydrochloride - prolonged release capsule, hard - 200mg - mebeverine hydrochloride (0002753459) 200mg - mebeverine
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - Αντινεοπλασματικοί παράγοντες - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - Ανοσοδιεγερτικά, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
lipidil nt 145mg film coated tablets
viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - fenofibrate - film coated tablets - 145mg - fenofibrate (0049562289) 145mg - fenofibrate
atehexal 100mg film coated tablets
hexal ag (0000003472) industriestrabe 25, holzkirchen, d-83607 - atenolol - film coated tablets - 100mg - atenolol (0029122687) 100mg - atenolol
atehexal 50mg film coated tablets
hexal ag (0000003472) industriestrabe 25, holzkirchen, d-83607 - atenolol - film coated tablets - 50mg - atenolol (0029122687) 50mg - atenolol